Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patients

Journal of Interventional Cardiac Electrophysiology

Volumn 28, Issue 2, 2010, Pages 117-123

  Khan, Faris ^a   Adelstein, Evan ^a   Saba, Samir ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Defibrillator; Dialysis therapy; Mortality; Renal insufficiency

Indexed keywords

AGED; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; CHRONIC KIDNEY FAILURE; DEFIBRILLATOR; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SURVIVAL;

AGED; CASE-CONTROL STUDIES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 79952044894     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-010-9484-6     Document Type: Article

References (20)

1. Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003). Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. American Journal of Kidney Diseases, 41, 1-12. (Pubitemid 36043346)
2. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. (2006). US Renal Data System UADRAoE-SRDitUS. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
3. Herzog, C. A. (2007). Can we prevent sudden cardiac death in dialysis patients? Clinical Journal of the American Society of Nephrology, 2, 410-412.
4. Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. New England Journal of Medicine, 352, 225-237. (Pubitemid 40110811)
5. Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., et al. (1996). Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. New England Journal of Medicine, 335, 1933-1940. (Pubitemid 26428217)
6. Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346, 877-883. (Pubitemid 34984635)
7. Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A., 3rd, Freedman, R. A., Gettes, L. S., et al. (2008). ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation, 117(21), e350-e408. Writing Committee to Revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
8. Mark, P. B., Johnston, N., Groenning, B. A., Foster, J. E., Blyth, K. G., Martin, T. N., et al. (2006). Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney International, 69, 1839-1845. (Pubitemid 43739213)
9. Chen-Scarabelli, C., & Scarabelli, T. M. (2007). Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients. Pacing and Clinical Electrophysiology, 30, 371-376. (Pubitemid 46426555)
10. Chonchol, M., Goldenberg, I., Moss, A. J., McNitt, S., & Cheung, A. K. (2007). Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction. American Journal of Nephrology, 27, 7-14. (Pubitemid 46364535)
11. Ito, I., Kono, K., Shinbo, G., Tadokoro, K., Abe, C., Takemura, N., et al. (2009). Implantable cardioverter defibrillator in maintenance hemodialysis patients with ventricular tachyarrhythmias: a single-center experience. Hemodialysis International, 13, 48-54.
12. Robin, J., Weinberg, K., Tiongson, J., Carnethon, M., Reddy, M., Ciaccio, C., et al. (2006). Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverterdefibrillator recipients. Heart Rhythm, 3, 1196-1201. (Pubitemid 44464149)
13. Wase, A., Basit, A., Nazir, R., Jamal, A., Shah, S., Khan, T., et al. (2004). Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. Journal of Interventional CardiacElectrophysiology, 11, 199-204. (Pubitemid 40949506)
14. Hreybe, H., Ezzeddine, R., Bedi, M., Barrington, W., Bazaz, R., Ganz, L. I., et al. (2006). Renal insufficiency predicts the time to first appropriate defibrillator shock. American Heart Journal, 151, 852-856.
15. Grothe, C., Belasco, A., Bettencourt, A., Diccini, S., Vianna, L., Pignatari, A., et al. (2009). Lethality of endocarditis due to S. aureus among patients on hemodialysis. Nephrology Nursing Journal, 36, 613-619.
16. Thomson, P., Stirling, C., Traynor, J., Morris, S., Mactier, R. (2010). A prospective observational study of catheter-related bacteraemia and thrombosis in a haemodialysis cohort: Univariate and multivariate analyses of risk association. Nephrology, Dialysis, Transplantation. doi:10.1093/ndt/gfp667
17. Cuculich, P. S., Sanchez, J. M., Kerzner, R., Greenberg, S. L., Sengupta, J., Chen, J., et al. (2007). Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing and Clinical Electrophysiology, 30, 207-213. (Pubitemid 46333676)
18. Hreybe, H., Razak, E., & Saba, S. (2007). Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter- defibrillator recipients. Pacing and Clinical Electrophysiology, 30, 1091-1095. (Pubitemid 47300648)
19. Herzog, C. A., Li, S., Weinhandl, E. D., Strief, J. W., Collins, A. J., & Gilbertson, D. T. (2005). Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney International, 68, 818-825. (Pubitemid 43323139)
20. de Bie, M. K., Lekkerkerker, J. C., van Dam, B., Gaasbeek, A., van Buren, M., Putter, H., et al. (2008). Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial-a prospective pilot study. Current Medical Research and Opinion, 24, 2151-2157.